An animal model for delayed hemolytic transfusion reactions

Transfusion Medicine Reviews

Volumn 15, Issue 4, 2001, Pages 305-317

  Ness, Paul M ^a   Shirey, R Sue ^a   Weinstein, Michael H ^a   King, Karen E ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMIUM 51; CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 6; TUMOR NECROSIS FACTOR; CHROMIUM;

ANIMAL MODEL; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; DISEASE SEVERITY; ERYTHROCYTE; FEVER; HEMATOCRIT; HEMOGLOBIN DETERMINATION; HEMOLYSIS; ISOTOPE LABELING; JAUNDICE; KIDNEY FAILURE; LABORATORY TEST; NONHUMAN; RABBIT; REVIEW; SEROLOGY; ANIMAL; BLOOD GROUP INCOMPATIBILITY; DISEASE MODEL; IMMUNOLOGY; MALE; TIME;

ANIMALS; BLOOD GROUP INCOMPATIBILITY; BLOOD TRANSFUSION; CHROMIUM RADIOISOTOPES; DISEASE MODELS, ANIMAL; HEMOLYSIS; MALE; RABBITS; TIME FACTORS;

EID: 0034788185     PISSN: 08877963     EISSN: None     Source Type: Journal    
DOI: 10.1053/tm.2001.26959     Document Type: Review

References (67)

1. The expanding boundaries of transfusion medicine
2. Cytokine production in IgG-mediated red cell incompatibility
3. The differentiation of delayed serologic and delayed hemolytic transfusion reactions: Incidence, long-term serologic findings, and clinical significance
4. Delayed hemolytic transfusion reactions: Evidence for complement activation involving allogeneic and autologous red cells
5. New concepts of delayed hemolytic transfusion reactions
6. Delayed hemolytic transfusion reaction: An immunologic hazard of blood transfusion
7. Delayed hemolytic transfusion reactions: Evidence of the need for an improved pretransfusion compatibility test
8. Hemolytic transfusion reactions: Frequency and clinical and laboratory aspects
9. Monocyte chemoattractant protein production in red cell incompatibility
10. In vitro production of Interleukin-1 receptor antagonist in IgG-mediated red cell incompatibility
11. Interleukin-1 and interleukin-1 antagonism
12. Tumor necrosis factor: An updated review of its biology
13. Interleukin-6 in biology and medicine
14. Recombinant IL-6/B cell stimulatory factor 2 augments murine antigen-specific antibody responses in vitro and in vivo
15. Cytokine roles in hemolytic and non-hemolytic transfusion reactions
16. Complement
17. Complement in transfusion medicine
18. Pathophysiology of immune hemolytic anemia
19. Evolution of the complement system
20. Molecular cloning and chromosomal localization of human membrane cofactor protein (MCP)
21. The gene encoding decay-accelerating factor (DAF) is located in the complement regulatory locus on the long arm of chromosome 1
22. CD59 expressed by human endothelial cells functions as a protective molecule against complement-mediated lysis
23. Species-specific restriction of complement by HRF20 (CD59) generated by cDNA transfection
24. The erythrocytes in paroxysmal hemoglobinuria of intermediate sensitivity to complement lysis
25. Molecular basis of the enhanced susceptibility of the erythrocytes of paroxysmal nocturnal hemoglobinuria to hemolysis in acidified serum
26. Amelioration of lytic abnormalities of paroxysmal nocturnal hemoglobinuria with decay-accelerating factor
27. Enhanced expression of the complement regulatory protein, membrane inhibitor of reactive lysis (CD59), is regulated at the level of transcription
28. Renal xenograft rerjection: Prolonging effect of captopril, ACE-inhibitors, prostacysclin and cobra venom factor
29. Prolonged survival of guinea pig to rat heart xenografts using repeated low doses of cobra venom factor
30. Complement receptor type 1 (C3b/C4b receptor; CD35) and complement receptor type 2 (C3d; Epstein-Barr virus receptor; CD21)
31. Anti-inflammatory and immunosuppressive effects of recombinant soluble complement receptors
32. The effect of soluble complement receptor type 1 on hyperacute xenograft rejection
33. Effect of repetitive doses of soluble human complement receptor type 1 on survival of discordant cardiac xenografts
34. Soluble human complement receptor type 1: In vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis
35. The initiation and enhancement of human red cell lysis by activators of the first component of complement and by first component esterase: Studies using normal red cells and red cells from patients with paroxysmal nocturnal hemoglobinuria
36. Transfusion in paroxysmal nocturnal hemoglobinuria
37. Paroxysmal nocturnal hemoglobinuria: The biochemical defects and the clinical syndrome
38. A fatal hemolytic transfusion reaction with acute autohemolysis
39. Hemolytic reactions following transfusions of blood of the homologous group
40. Combined sickle cell disease and autoimmune hemolytic anemia
41. Posttransfusion crises in sickle cell anemia: Role of delayed hemolytic reactions to transfusion
42. Delayed hemolytic transfusion reactions in sickle cell disease: Simultaneous destruction of recipients red cells
43. Malaria: Host-defense mechanisms and complications
44. Cause of anaemia in malaria
45. Normal biochemical and hematological values in New Zealand white rabbits
46. Hematologic values of New Zealand white rabbits determined by automated flow cytometry
47. Specialized research applications: Serological genetics
48. On immune isoagglutinins in rabbits
49. On immune isoagglutinins in rabbits, second paper
50. Experimental erythroblastosis fetalis in rabbits: I. Characterization of a pair of allelic blood group factors and their specific immune isoantibodies
51. Experimental erythroblastosis fetalis in rabbits: II. The passage of blood group antigens and their specific isoantibodies across the placenta
52. Antibody-mediated immune suppression to the Rh factor: Animal models suggesting mechanism of action
53. The effect of cyclosporin A on the primary immune response to allogeneic red cells in rabbits
54. A
55. Normal red cell survival in the rabbit
56. The survival of radiochromium-tagged erythrocytes in pigeons, ducks and rabbits
57. The survival of virus-treated erythrocytes in normal and splenectomized rabbits
58. Recommended mehtod for radioisotope red cell survival studies
59. Direct evidence of bystander hemolysis in delayed hemolytic transfusion reactions
60. Serologic findings in delayed hemolytic transfusion reactions (DHTR) produced in an animal model
61. Activation of rabbit C3: Studies of the generation of cleavage products in vitro and their metabolism in vivo
62. Genetic deficiency of a complement component C8 in the rabbit: Evidence of a translational defect in the α-γ subunit
63. Deficiency of the sixth component of complement in rabbits with an inheritied complement defect